Wfa Asset Management Corp Bristol Myers Squibb CO Transaction History

Wfa Asset Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 May 24, 2024	SELL	$48.48 - $57.85 $16,968 - $20,247	-350 Reduced 35.82%	627 $32.2 Million
Q4 2023 Jan 31, 2024	SELL	$48.48 - $57.85 $16,968 - $20,247	-350 Reduced 35.82%	627 $32.2 Million
Q3 2023 May 24, 2024	BUY	$57.89 - $64.73 $56,558 - $63,241	977 New	977 $56.7 Million
Q3 2023 Oct 13, 2023	BUY	$57.89 - $64.73 $1,563 - $1,747	27 Added 2.84%	977 $56.7 Million
Q1 2023 Oct 13, 2023	BUY	$65.71 - $74.53 $62,424 - $70,803	950 New	950 $65.8 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Wfa Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Wfa Asset Management Corp with notifications on news.